Latest News and Press Releases

Dyesol Limited / Miscellaneous/Miscellaneous 27.01.2010 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the...

Follow up of ChronVac-C®-study with a 5th dose commenced The first patient has now received a 5th dose of the therapeutic vaccine ChronVac-C® without complications. This is one of up to three...

Elcoteq SE Pörssitiedote 27.1.2010 klo 8.35 (EET) Elcoteq SE ja Nokia ovat tänään allekirjoittaneet sopimuksen yhteistyöstä, jossa Elcoteq tarjoaa Nokian yhteistyökumppanina Nokian asiakkaiden...

Elcoteq SE Stock Exchange Release January 27, 2010 at 8:35 am (EET) Elcoteq SE and Nokia Corporation have signed an agreement that qualifies Elcoteq as a partner to provide Nokia's customers with...

Uppföljning av ChronVac-C®-studie med 5:e dos nu inledd Den första patienten har nu erhållit en 5:e dos av det behandlande vaccinet ChronVac-C® utan komplikationer. Detta är en av upp till tre...

Elcoteq SE Pörssitiedote 27.1.2010 klo 8:30 (EET) Osana aiemmin julkistettua taseen uudelleenjärjestelyä Elcoteq SE on päättänyt tänään laskea liikkeeseen hybridiehtoisia arvopapereita 29 miljoonan...

Elcoteq SE Stock Exchange Release January 27, 2010 at 08:30 am (EET) As part of its previously announced balance sheet restructuring, Elcoteq SE has today decided to issue EUR 29 million hybrid...

Press Release January 27, 2010 Swedbank cancels variable remuneration for 2009 The Board of Swedbank has decided to cancel variable remuneration for 2009, where employment contracts give the bank a...

Pressmeddelande 27 januari 2010 Swedbank drar tillbaka rörlig ersättning för 2009 Swedbanks styrelse har beslutat att inte betala ut rörlig ersättning för 2009 där anställningsavtalen ensidigt ger...

EpiCept Receives Orphan Drug Designation for EpiCept™ NP-1 in U.S. TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)...